血管疾病中的内皮氧化合成酶:从奇迹到威胁
Ulrich Förstermann1, Thomas Münzel
1Department of Pharmacology, Johannes Gutenberg University, Mainz, Germany. ulrich.forstermann@uni-mainz.de
Circulation
|April 6, 2006
概括
心血管风险因素通过脱离内皮NO合成酶 (eNOS) 来损害氧化 (NO) 生产. 补充四基生物素 (BH4) 可以恢复eNOS功能和血管健康.
科学领域:
- 血管生物学和医学 血管生物学和医学
- 生物化学和分子生物学
- 心血管生理学心血管生理学
背景情况:
- 内皮氧化合成酶 (eNOS) 在血管中产生保护性氧化 (NO).
- eNOS的功能取决于基质L-氨酸,酶二元化,以及辅因子 (6R) -5,6,7,8-四-L-生物素 (BH4).
- 心血管风险因素增加了活性氧物种 (ROS),氧化BH4并损害eNOS功能.
研究的目的:
- 在心血管风险条件下调查BH4在eNOS功能障碍中的作用.
- 探索ROS对BH4水平和eNOS活动的影响.
- 评估BH4补充剂在恢复eNOS功能方面的治疗潜力.
主要方法:
- 关于eNOS功能,氧化应激和心血管风险因素的文献综述.
- 分析连接ROS,BH4氧化和eNOS解的机制.
- 检查涉及BH4,叶酸和维生素C补充剂的研究.
主要成果:
- 心血管风险因素会增加ROS,导致BH4氧化和eNOS脱.
- 未结合的eNOS产生超氧化物 (O2*-) 而不是NO,导致氧化应激.
- 在各种模型和患者中,BH4补充剂已被证明可以逆转eNOS功能障碍.
结论:
- BH4对于维持eNOS功能至关重要;它的耗尽促进了血管氧化应激.
- 恢复BH4水平,可能通过补充BH4,叶酸或维生素C,可以纠正eNOS功能障碍.
- 准BH4代谢为管理与内皮功能障碍相关的心血管疾病提供了一个有希望的策略.
相关概念视频
Coronary Artery Disease II: Pathophysiology
894
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
894
Hypertension II: Pathophysiology
1.3K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
Nitric Oxide Signaling Pathway
6.6K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.6K
Regulation of Angiogenesis and Blood Supply
3.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Antihypertensive Drugs: Vasodilators
2.4K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.4K
Mechanism of Angiogenesis
7.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.4K


